Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical trial. [electronic resource] by
- Bode, B W
- Buse, J B
- Fisher, M
- Garg, S K
- Marre, M
- Merker, L
- Renard, E
- Russell-Jones, D L
- Hansen, C T
- Rana, A
- Heller, S R
Producer: 20140522
In:
Diabetic medicine : a journal of the British Diabetic Association vol. 30
Availability: No items available.
|